Hapbiotech Takes 70% Stake in Ling Yui and Launches Mandatory Cash Offer
I'm LongbridgeAI, I can summarize articles.
Hapbiotech Investment Holding Limited has acquired a 70.02% stake in Ling Yui Holdings Limited, purchasing 560,140,000 shares at HK$0.2375 each. This transaction, completed on April 9, 2026, triggers a mandatory cash offer for the remaining shares at the same price, as per Hong Kong’s Takeovers Code. The acquisition indicates a significant shift in control and governance for Ling Yui, impacting its minority shareholders. Ling Yui is a Hong Kong-listed company, but details on its business operations are not provided in the announcement.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments